Skip to main content
. Author manuscript; available in PMC: 2010 Aug 18.
Published in final edited form as: J Neuroimmunol. 2009 Jun 21;213(1-2):47–59. doi: 10.1016/j.jneuroim.2009.06.002

Figure 2.

Figure 2

Phosphorylation of Pyk-2 is decreased with increasing concentrations of PMS-601 in HIV-1ADA infected MDM. A Confocal microscopy of human MDM infected with HIV-1ADA for 5 d and then stained for anti-paxillin (green) and anti-phosphorylated Pyk-2 (red); images merged. B Graph of phosphorylated Pyk2 (p-Pyk2) in HIV-1ADA infected human MDM treated with increasing concentrations of PMS-601 as measured by MFI using in situ ELISA assay. In situ ELISA experiments are representative of 6 replicate assays performed with MDM from 3 different donors. Data are expressed as means ± S.E.M. * P≤0.05 *** P≤0.001